Research Article

Antieosinophil Antibodies Alone or in Combination with Antineutrophil Cytoplasmic Antibodies (ANCA) Detected in Different Autoimmune Conditions

Table 2

The clinical characteristics and disease profile of the AEOSA+/ANCA+ individual patients.

Age (years)SexAnti-TPOAnti-TGAnti-MPOSMA/AMA/Par (IF)Liver antibodiesAEOSA specificityDisease history
GI/Liver diseaseThyroid diseaseOther diseases

D166MNegativePositiveNegativeNegativeEPX+Vasculitis (MPA)
D257MNegativePositiveNegativeNegativeEPX+Kidney disease unspecified
D348FNegativeNegativePositiven.a.NegativeEPX borderlineLiver steatosisHyperthyroidismFibromyalgia, vitiligo, pulmonary embolism
D418FNegativePositiveNegativeNegativeEPX−Vasculitis (GPA)
D569FNegativeNegativePositiveNegativeEPX+Vasculitis (MPA), breast cancer, pituitary tumor, history of alcohol abuse
D671Mn.a.Positiven.a.n.a.n.a.
D777FNegativePositiveNegativeNegativeEPX+
ECP+
EDN+
Chronic laryngitis, chronic rhinitis, sinusitis, duodenitis, COPD, diabetes type II
D870FNegativePositivePar 640Negativen.a.Atrophic gastritisThyrotoxicosisNonallergic asthma, primary hyperparathyroidism, polyneuropathy
D970FNegativeNegativeSMA 80NegativeEPX+
ECP+
Ulcerative colitisHypothyroidismLichen planopilaris, diabetes type II, chronic kidney failure
D1080MBorderlineBorderlinePositivePar 80LC-1(+)
gp210+
3E(BPO)+
EPX+HypothyroidismMDS, vasculitis (giant cell arthritis)
D1143FPositivePositiveNegativeSLA/LP+
gp210+
PML+
LC-1(+)
EPX+HyperthyroidismEhler–Danlos syndrome, asthma
D1236PositivePositiven.a.n.a.EPX+Hashimoto thyroiditisVasculitis (IgA nephritis)
D1366FPositivePositivePositivePar 80M2+EPX+
ECP+
Pernicious anemiaHashimoto thyroiditisDiabetes mellitus type I, vitiligo, skin vasculitis/urticaria
D1436FBorderlinePositiveNegativeNegativen.a.SLE, pericarditis, urticaria
D1571FPositivePositiveSMA 80LKM-1(+)n.a.Recurrent urticaria, allergic rhinitis/asthma
D1671FNegativeNegativeNegativePar 640LC-1(+)
LKM-1(+)
n.a.Pericarditis, palmoplantar psoriasis

Liver antibody profile tested includes AMA, AMA-M2, 3E (BPO), PML, Sp100, gp210, LKM-1, LC-1, and SLA/LP. Abbreviations: TPO, thyroid peroxidase; TG, thyroglobulin, MPO, myeloperoxidase; IF, immunofluorescence; SMA, smooth muscle antibody; AMA, antimitochondrial antibodies; Par, parietal cell antibodies; AEOSA, antieosinophil cytoplasmic antibodies; GI, gastrointestinal; EPX, eosinophil peroxidase; ECP, eosinophil cationic protein; EDN, eosinophil-derived neurotoxin; MPA, microscopic polyangitis; GPA, granulomatosis with polyangiitis; COPD, chronic obstructive pulmonary disease; SLE, systemic lupus erythematosus; n.a., not available.